Wolters Kluwer, Health, a global provider of information and point of care solutions for the healthcare industry, has entered into a multi-year agreement with the American Society of Clinical Oncology, Inc. (ASCO®), the world’s leading organisation of its kind representing nearly 45,000 oncology professionals who care for people with cancer. Under this agreement, beginning in January 2021, Wolters Kluwer will publish ASCO’s portfolio of five medical specialty journals, including its flagship publication the Journal of Clinical Oncology (JCO), one of the most highly cited oncology journals in the world.
Wolters Kluwer will focus on expanding ASCO’s journal readership globally through access and distribution on the Ovid® medical research platform, among other channels, as well as the potential to reach members and practitioners through new digital channels.
ASCO’s journal publications include: Journal of Clinical Oncology (JCO); JCO Oncology Practice (JCO OP); JCO Clinical Cancer Informatics (JCO CCI); JCO Precision Oncology (JCO PO); and JCO Global Oncology (JCO GO).
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.Click here to read the original press release.